Discovery of 2-chloro-N-((4,4-difluoro-1-hydroxycyclohexyl)methyl)-5-(5-fluoropyrimidin-2-yl)benzamide as a potent and CNS penetrable P2X7 receptor antagonist

Bioorg Med Chem Lett. 2010 May 15;20(10):3107-11. doi: 10.1016/j.bmcl.2010.03.094. Epub 2010 Mar 30.

Abstract

Focused SAR studies were carried out around 5-heteroaryl and 1-amide portions of the 2-chlorobenzamide scaffold, resulting in the discovery of a potent, metabolically stable and centrally penetrable antagonist against P2X(7) receptor.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / chemical synthesis
  • Anti-Inflammatory Agents / chemistry*
  • Anti-Inflammatory Agents / pharmacokinetics
  • Benzamides / chemical synthesis
  • Benzamides / chemistry*
  • Benzamides / pharmacokinetics
  • Central Nervous System / drug effects
  • Drug Discovery
  • Humans
  • Male
  • Microsomes, Liver / metabolism
  • Purinergic P2 Receptor Antagonists*
  • Pyrimidines / chemical synthesis
  • Pyrimidines / chemistry*
  • Pyrimidines / pharmacokinetics
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Purinergic P2 / metabolism
  • Receptors, Purinergic P2X7
  • Structure-Activity Relationship

Substances

  • Anti-Inflammatory Agents
  • Benzamides
  • P2RX7 protein, human
  • Purinergic P2 Receptor Antagonists
  • Pyrimidines
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2X7